Answer
Yes. Venous and arterial thromboembolic events are recognised serious adverse effects, particularly when other thrombotic risk factors are present.
Sources for this answer
- NovoSeven 2mg (100 KIU) powder and solvent for solution for injection — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.